深入研究心血管等离子体蛋白学:当前平台的机遇和局限性
Pich Chhay1,2, Owen Tang1,2, Lizhuo Ai3
1Cardiovascular Discovery Group, Kolling Institute of Medical Research, Northern Sydney Local Health District, Australia (P.C., O.T., M.P.G., G.A.F.).
Circulation. Genomic and precision medicine
|October 6, 2025
概括
蛋白质组学为早期检测冠状动脉疾病 (CAD) 提供了新的希望. 本综述探讨了蛋白质组学平台,用于发现新的生物标志物,以改善心血管疾病风险分层和患者结果.
科学领域:
- 心血管研究研究心血管研究
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
背景情况:
- 冠状动脉疾病 (CAD) 是全球主要的死亡原因.
- 尽管有进展,急性冠状动脉综合征仍然存在,需要更好的早期检测和风险分层.
- 蛋白质组学为识别心血管疾病中的新生物标志物提供了一个有前途的方法.
研究的目的:
- 为冠状动脉疾病研究提供主要蛋白质组平台的最新概述.
- 讨论各种蛋白质组学技术的优点,局限性和应用.
- 突出蛋白质组学在发现用于早期CAD检测和风险评估的新生物标志物的潜力.
主要方法:
- 对主要蛋白质组平台及其方法的审查.
- 用蛋白质组学分析最近的冠状动脉疾病研究.
- 蛋白质组学数据与临床信息和其他组学学科的整合.
主要成果:
- 蛋白质组学能够对蛋白质丰富度和与心血管疾病相关的修改进行高通量分析.
- 可以检测到低丰度的蛋白质,提供对心脏病理生理学和潜在的新生物标志物的见解.
- 了解技术的局限性对于有效的生物标志物发现至关重要.
结论:
- 蛋白质组学具有重大潜力,可以彻底改变冠状动脉疾病的及时检测和管理.
- 将蛋白质组学与临床数据和其他组学相结合,可以增强理解并改善风险分层.
- 在临床试验中严格验证对于将生物标志物发现转化为临床实践至关重要.
相关概念视频
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...


